Cargando…
Recombinant TIMP-1-GPI inhibits growth of fibrosarcoma and enhances tumor sensitivity to doxorubicin
Fibrosarcomas show a high incidence of recurrence and general resistance to apoptosis. Limiting tumor regrowth and increasing their sensitivity to chemotherapy and apoptosis represent key issues in developing more effective treatments of these tumors. Tissue inhibitor of metalloproteinase 1 (TIMP-1)...
Autores principales: | Bao, Q., Niess, H., Djafarzadeh, R., Zhao, Y., Schwarz, B., Angele, M. K., Jauch, K.-W., Nelson, P. J., Bruns, C. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156787/ https://www.ncbi.nlm.nih.gov/pubmed/23934106 http://dx.doi.org/10.1007/s11523-013-0294-5 |
Ejemplares similares
-
Recombinant GPI-Anchored TIMP-1 Stimulates Growth and Migration of Peritoneal Mesothelial Cells
por: Djafarzadeh, Roghieh, et al.
Publicado: (2012) -
FT-GPI, a highly sensitive and accurate predictor of GPI-anchored proteins, reveals the composition and evolution of the GPI proteome in Plasmodium species
por: Sauer, Lena M., et al.
Publicado: (2023) -
Genetic engineering of mesenchymal stromal cells for cancer therapy: turning partners in crime into Trojan horses
por: Niess, Hanno, et al.
Publicado: (2016) -
Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model
por: Zabielska-Koczywąs, Katarzyna, et al.
Publicado: (2018) -
PredGPI: a GPI-anchor predictor
por: Pierleoni, Andrea, et al.
Publicado: (2008)